STUDY ON FACTORS RELATED TO DYSLIPIDEMIA IN PATIENTS WITH END-STAGE RENAL DISEASE WHO ARE TREATED BY HEMODIALYSIS
Main Article Content
Abstract
Chronic kidney disease (CKD) is a global health problem, the incidence of chronic kidney disease is increasing. Dyslipidemia is a common problem in patients with CKD, it increases the risk of cardiovascular disease in patients with CKD. Managing dyslipidemia and the factors associated with dyslipidemia is one of the goals of treatment for patients with CKD. The aim of study: Study the relationship between dyslipidemia with: duration of dialysis, causes of CKD, hypertesion, blood hemoglobin, total blood protein, serum albumin in patients with ESRD who are treated by hemodialysis. Methods: A cross - sectional study on 60 patients with ESRD who are treated by hemodialysis in Nghe An General Hospital. Results: (1) Level of total cholesterol, triglyceride, LDL – C and TC/HDL - C, LDL/HDL - C in patients with CKD who are treated by hemodialysis is not statistically different between pateints with hemodialysis less than 1 year and over 1 year, between the causes of CKD, between hypertensive and not hypertensive groups; (2) Level of triglyceride in group of patients with hemoglobin < 90g/l is higher than that of group of patients with hemoglobin ≥ 90g/l; (3) Level of cholestrol in group of patients with protein < 65 g/l is higher than that of group with protein ≥ 65g/l; (4) Level of cholestrol in group of patients with albumin < 35 g/l is higher than that of group with albumin ≥ 35g/l.
Article Details
Keywords
Dyslipidemia, CKD
References
2. Nguyễn Thị Phòng (2007), “Nghiên cứu rối loạn lipid máu ở bệnh nhân suy thận mạn giai đoạn III - IV”. Luận án chuyên khoa cấp 2, Trường đại học y dược Huế.
3. Võ Tam và cộng sự (2011), Khảo sát rối loạn lipid máu ở bệnh nhân suy thận giai đoạn cuối lọc màng bụng”, Trường đại học y dược Huế.
4. Ivana Mikolasevic, Marta Zutelija, Vojko mavrinac (2017), Dyslipidemia in patients with chronic kidney disease: etiology and management, Int J Nephrol Renovasc Dis, 10; 35-45.
5. KDIGO (2012), KDIGO 2012 Clinical practice guideline for the Evaluation and management of chronic kidney disease, Kidney International supplements.
6. Joana Mesquita, Ana Valera (2010), Dyslipidemia in renal disease: Causes, consequences and treatment, Endocinologia Y Nutricion, 57(9): 440-448.
7. Sarnak MJ, Levey AS, Schoolwerth AC (2003), Kidney disease as a risk factor for development of cardiovascular disease, Hypertesion, 42(5): 1050-1065.